Clinical Study

Biological Behavior of Papillary Carcinoma of the Thyroid Including Squamous Cell Carcinoma Components and Prognosis of Patients Who Underwent Locally Curative Surgery

Table 2

Intraoperative and pathological findings and prognosis of 10 patients with PTC-SCC.

Patient no.Surgical designsResectionExtrathyroid extensionPathology (primary)Pathology (LN meta)Adjuvant therapiesCarcinoma recurrenceOutcome after diagnosis

1TT + MNDR0?Yes **PTC > SCC (10%)PTC *chemoBone18 m DOC
2CT + MNDR0xxPTC > SCC (<10%)x x43 m ANEC
3MNDR0xxPTC > SCC (40%) > UCChemo x33 m AWC
4TT + CNDR0YesSCC (40%) > UC > PTCPTC *chemo L a r y n , Bone23 m DOC
5TT + MND R0YesSCC (80%) > PTC (tall)PTCChemo + EBRTSkin, local18 m ANEC
6TT + MNDR0?YesPTC > SCC (<10%)PTCx x14 m ANEC
7TT + MND R0YesPTC (tall) > SCC (40%)PTCEBRT x13 m ANEC
8LI + MNDR0YesPTC (tall) > SCC (10%)PTC *chemo + EBRT x9 m ANEC
9TT + MNDR0YesPTC (tall) > SCC (20%)PTCImmunotherapyLung9 m DOC
10TT + MMD R1YesPTC > SCC (20%)PTCChemo for lung carcinomax5 m ANEC

*Preoperative chemotherapy was also performed. R e c u r r e n c e of UC. **A > B indicates A occupied a larger portion than B.
TT: total thyroidectomy, CT: completion total thyroidectomy, LI: lobectomy with is thymectomy, CND: central node dissection, MND: modified radical neck dissection, EBRT; external beam radiotherapy.
DOC; Died of carcinoma.
ANEC: Alive with no evidence of Carcinoma.
AWC: Alive with carcinoma.